Search Results Search Sort by RelevanceMost Recent Medicine and Society Apr 2022 Language and Health (In)Equity in US Latinx Communities Zackary Berger, MD, PhD and Yael Peled, DPhil In US health care, language and linguistic difference are often conceived in discrete, instrumental, and monolithic terms. AMA J Ethics. 2022;24(4):E313-318. doi: 10.1001/amajethics.2022.313. Case and Commentary Feb 2022 ¿Cómo deben los médicos determinar la disposición de un paciente traumatizado para regresar al trabajo? Tabitha E. H. Moses, MS and Arash Javanbakht, MD AMA J Ethics. 2022;E111-119. doi: 10.1001/amajethics.2022.111. Case and Commentary Feb 2022 ¿Debería un médico alguna vez violar los protocolos SWAT o TEMS durante un incidente con múltiples víctimas? Brandon Morshedi, MD, DPT and Faroukh Mehkri, DO AMA J Ethics. 2022;E120-125. doi: 10.1001/amajethics.2022.120. Policy Forum Feb 2022 ¿Cómo deberían los clínicos tácticos ayudar a hacer un uso más justo de la fuerza? David Callaway, MD and Faroukh Mehkri, DO AMA J Ethics. 2022;E133-139. doi: 10.1001/amajethics.2022.133. Policy Forum Feb 2022 ¿Cómo se debería equilibrar el riesgo para el personal táctico con los requerimientos clínicos y ética de rescate? Mollie V. Williams, MD, MPH and Olaitan Ajisafe, MD, PharmD AMA J Ethics. 2022;E140-144. doi: 10.1001/amajethics.2022.140. Podcast Feb 2022 Author Interview: “How Should Clinicians Determine a Traumatized Patient’s Readiness to Return to Work?” Tabitha E. H. Moses, MS joins Ethics Talk to discuss her article, coauthored with Dr Arash Javanbakht: “How Should Clinicians Determine a Traumatized Patient’s Readiness to Return to Work?” Case and Commentary May 2022 Do You Know How to Assess Risks Posed by Over-the-Counter Vitamin A Supplements? Dina H. Zamil, Emily K. Burns, Ariadna Perez-Sanchez, MD, and Rajani Katta, MD Label analysis is key to educating patients about risks of vitamin A-containing supplements. AMA J Ethics. 2022;24(5):E376-381. doi: 10.1001/amajethics.2022.376. Medical Education May 2022 Is My Patient Taking an Unsafe Dietary Supplement? Ilisa B. G. Bernstein, PharmD, JD and Karin L. Bolte, JD Dietary supplements can have side effects; interact with medications, food, or other supplements; or be unsafe. AMA J Ethics. 2022;24(5):E390-395. doi: 10.1001/amajethics.2022.390. Policy Forum May 2022 What Should Dietary Supplement Oversight Look Like in the US? Elizabeth Richardson, MSc, Farzana Akkas, MSc, and Amy B. Cadwallader, PhD Statutory limitations prevent the FDA from effectively regulating dietary supplements and have generated numerous calls for reform. AMA J Ethics. 2022;24(5):E402-409. doi: 10.1001/amajethics.2022.402. Policy Forum May 2022 Which Features of Dietary Supplement Industry, Product Trends, and Regulation Deserve Physicians’ Attention? Amy B. Cadwallader, PhD and AMA Council on Science and Public Health Illegal, fraudulent, adulterated, or improperly labeled products should be regarded as sources of possible clinical and ethical harm to patients. AMA J Ethics. 2022;24(5):E410-418. doi: 10.1001/amajethics.2022.410. Pagination First page « First Previous page ‹ Previous Page 1 Page 2 Page 3 Current page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Next page Next › Last page Last »
Medicine and Society Apr 2022 Language and Health (In)Equity in US Latinx Communities Zackary Berger, MD, PhD and Yael Peled, DPhil In US health care, language and linguistic difference are often conceived in discrete, instrumental, and monolithic terms. AMA J Ethics. 2022;24(4):E313-318. doi: 10.1001/amajethics.2022.313.
Case and Commentary Feb 2022 ¿Cómo deben los médicos determinar la disposición de un paciente traumatizado para regresar al trabajo? Tabitha E. H. Moses, MS and Arash Javanbakht, MD AMA J Ethics. 2022;E111-119. doi: 10.1001/amajethics.2022.111.
Case and Commentary Feb 2022 ¿Debería un médico alguna vez violar los protocolos SWAT o TEMS durante un incidente con múltiples víctimas? Brandon Morshedi, MD, DPT and Faroukh Mehkri, DO AMA J Ethics. 2022;E120-125. doi: 10.1001/amajethics.2022.120.
Policy Forum Feb 2022 ¿Cómo deberían los clínicos tácticos ayudar a hacer un uso más justo de la fuerza? David Callaway, MD and Faroukh Mehkri, DO AMA J Ethics. 2022;E133-139. doi: 10.1001/amajethics.2022.133.
Policy Forum Feb 2022 ¿Cómo se debería equilibrar el riesgo para el personal táctico con los requerimientos clínicos y ética de rescate? Mollie V. Williams, MD, MPH and Olaitan Ajisafe, MD, PharmD AMA J Ethics. 2022;E140-144. doi: 10.1001/amajethics.2022.140.
Podcast Feb 2022 Author Interview: “How Should Clinicians Determine a Traumatized Patient’s Readiness to Return to Work?” Tabitha E. H. Moses, MS joins Ethics Talk to discuss her article, coauthored with Dr Arash Javanbakht: “How Should Clinicians Determine a Traumatized Patient’s Readiness to Return to Work?”
Case and Commentary May 2022 Do You Know How to Assess Risks Posed by Over-the-Counter Vitamin A Supplements? Dina H. Zamil, Emily K. Burns, Ariadna Perez-Sanchez, MD, and Rajani Katta, MD Label analysis is key to educating patients about risks of vitamin A-containing supplements. AMA J Ethics. 2022;24(5):E376-381. doi: 10.1001/amajethics.2022.376.
Medical Education May 2022 Is My Patient Taking an Unsafe Dietary Supplement? Ilisa B. G. Bernstein, PharmD, JD and Karin L. Bolte, JD Dietary supplements can have side effects; interact with medications, food, or other supplements; or be unsafe. AMA J Ethics. 2022;24(5):E390-395. doi: 10.1001/amajethics.2022.390.
Policy Forum May 2022 What Should Dietary Supplement Oversight Look Like in the US? Elizabeth Richardson, MSc, Farzana Akkas, MSc, and Amy B. Cadwallader, PhD Statutory limitations prevent the FDA from effectively regulating dietary supplements and have generated numerous calls for reform. AMA J Ethics. 2022;24(5):E402-409. doi: 10.1001/amajethics.2022.402.
Policy Forum May 2022 Which Features of Dietary Supplement Industry, Product Trends, and Regulation Deserve Physicians’ Attention? Amy B. Cadwallader, PhD and AMA Council on Science and Public Health Illegal, fraudulent, adulterated, or improperly labeled products should be regarded as sources of possible clinical and ethical harm to patients. AMA J Ethics. 2022;24(5):E410-418. doi: 10.1001/amajethics.2022.410.